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Background: Mice with the gene encoding betaine-homocysteine S-methyltransferase deleted (Bhmt/) have absent
hepatic BHMT activity and reduced fat mass.
Results: Bhmt/ mice have increased energy expenditure, reduced fat synthesis, and enhanced glucose oxidation in white
adipose tissue.
Conclusion: BHMT plays a role in energy homeostasis.
Significance: Liver BHMT activity affects adipose tissue metabolism.
Betaine-homocysteine S-methyltransferase (BHMT) cata-
lyzes the synthesis of methionine from homocysteine. In our
initial report, we observed a reduced body weight in Bhmt/
mice. We initiated this study to investigate the potential role of
BHMT in energy metabolism. Compared with the controls
(Bhmt/), Bhmt/ mice had less fat mass, smaller adipocytes,
and better glucose and insulin sensitivities. Compared with the
controls,Bhmt/ mice had increased energy expenditure, with
no changes in food intake, fat uptake or absorption, or in loco-
motor activity. The reduced adiposity in Bhmt/ mice was not
due to hyperthermogenesis. Bhmt/ mice failed to maintain a
normal body temperature upon cold exposure because of lim-
ited fuel supplies. In vivo and ex vivo tests showed that Bhmt/
mice had normal lipolytic function. The rate of 14C-labeled fatty
acid incorporated into [14C]triacylglycerol was the same in
Bhmt/ and Bhmt/ gonadal fat depots (GWAT), but it was
62% lower in Bhmt/ inguinal fat depots (IWAT) compared
with that of Bhmt/ mice. The rate of 14C-labeled fatty acid
oxidation was the same in both GWAT and IWAT from
Bhmt/ and Bhmt/ mice. At basal level, Bhmt/ GWAT
had the same [14C]glucose oxidation as did the controls. When
stimulated with insulin, Bhmt/ GWAT oxidized 2.4-fold
more glucose than did the controls. Compared with the con-
trols, the rate of [14C]glucose oxidation was 2.4- and 1.8-fold
higher, respectively, in Bhmt/ IWAT without or with insulin
stimulus. Our results show for the first time a role for BHMT in
energy homeostasis.
Betaine-homocysteine S-methyltransferase (BHMT)2 is an
enzyme predominantly found in the liver in rodents (1), and it
plays an essential role in regulating one-carbon metabolism.
BHMT catalyzes the formation of the amino acid methionine
from homocysteine using the choline metabolite betaine as the
methyl donor. BHMT deficiency leads to elevated betaine and
homocysteine concentrations and reduced choline concentra-
tion (2). BHMT also influences hepatic lipid accumulation via
altering phosphatidylcholine (PtdCho) concentration. BHMT
exerts this effect through two mechanisms. First, choline, the
precursor of betaine, can alternatively be used to make PtdCho
via the Kennedy pathway. Second,methionine, the end product
of BHMT, is the precursor of S-adenosylmethionine, which is
required for the synthesis of PtdCho fromphosphatidylethano-
lamine by the enzyme phosphatidylethanolamine methyltrans-
ferase. BHMT overexpression increases PtdCho synthesis,
leading to reduced hepatic lipid accumulation (3), whereas
BHMT deficiency leads to fatty liver (2). Although the role of
BHMT in hepatic lipidmetabolismhas been elucidated, there is
no previous evidence that BHMT plays a role in whole body
energy metabolism and adiposity.
We observed that Bhmt-deficient (Bhmt/) mice had a
lower body weight from 5 to 9 weeks of age compared with wild
type littermates (2). Magnetic resonance image (MRI) analysis
and dissection of adipose fat depots revealed that the reduced
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body weight observed in Bhmt/ mice was due to reduced fat
depots. These results suggested thatBhmt-deficientmicemight
have problems with energy metabolism. This study aims to
examine the metabolic perturbations that lead to the reduced
adiposity observed in Bhmt/ mice. Homeostasis of energy
stores is regulated by mechanisms, including modulation of
metabolic rate and thermogenesis, control of metabolite fluxes
among various organs, andmodulation of fuel synthesis and use
within tissues. We present evidence that Bhmt/ mice have
reduced adiposity due to increased whole body metabolic rate,
impaired triglyceride synthesis, and enhanced glucose oxida-
tion in white adipose tissue (WAT).
EXPERIMENTAL PROCEDURES
Generation and Maintenance of Mice—The strategy used to
generate Bhmt/ mice was as described previously (2).
Bhmt/ mice and their wild type littermates were of a C57Bl/
6sv129 genetic background and were continuously back-
crossed toC57Bl/6mice. Generations F3 to F5were used in this
study. The animals were kept in a temperature-controlled envi-
ronment at 24 °C and exposed to a 12-h light and dark cycle. All
animals received AIN-76A pelleted diet with 1.1 g/kg choline
chloride (Dyets, Bethlehem, PA). The Institutional Animal
Care andUse Committee of theUniversity of North Carolina at
Chapel Hill approved all experimental protocols.
BHMTWestern Blot—Mice were anesthetized by inhalation
of isoflurane (Hospira, Lake Forest, IL). Tissues were harvested,
snap-frozen, pulverized under liquid nitrogen, and stored at
80 °C until used.Western blot analysis was performed in liver
and adipose homogenates as described previously (4).
Metabolic Studies—Body composition was determined in 7-
and 14-week-old mice by MRI (EchoMRI-100, Echo Medical
Systems, LLC, Houston). Core temperature was measured in
7-week-old mice using a rectal probe thermometer (Ther-
malert TH-5, Physitemp, Clifton, NJ). Food intake, oxygen con-
sumption (VO2), carbon dioxide release (VCO2), and locomo-
tor activity were measured every 27 min from individually
housed mice (7-week-old) using indirect calorimetry (TSE Sys-
tems, Germany) with an airflow of 0.25 liter/min. Locomotor
activity was measured using infrared technology as the counts
of three-dimensional beam breaking (X total, Y total, and Z
total). Respiratory exchange ratio (RER) was calculated as
VCO2/VO2. Mice were acclimated to the chambers for 24 h,
and data were collected during the following 24 h. Stool sam-
ples were collected, and TAG was extracted using the Folch
method (5) and measured colorimetrically (Sigma). For cold
tolerance tests, 7-week-old mice were fasted for 4 h before
being exposed to cold (4 °C) without food or bedding. Core
temperature was measured at base line and every 15 min.
Mice were removed from the cold room when body tempera-
ture dropped below 28 °C.
Biochemical Assays—An oral fat load test was performed by
gavaging 7-week-old mice with 10 l/g BW olive oil after an
overnight fast. Blood was collected retroorbitally at base line, 1,
2, 4, and 6h, andplasmaTAGwasmeasuredwith a colorimetric
assay (Sigma). Glucose and insulin tolerance tests were per-
formed by intraperitoneally injecting either glucose (2.5 g/kg
BW) or human insulin (1 unit/kg BW, Novo Nordisk Inc.,
Princeton, NJ) to 7-week-old mice after a 6- or 4-h fast, respec-
tively. Blood glucose was measured at base line, 15, 30, 60, and
120 min by tail nick using a calibrated glucometer (One Touch
Ultra, LifeScan, Inc., Milpitas, CA).
Plasma Metabolites—Plasma insulin (Ultra-sensitive Mouse
Insulin ELISA kit, Crystal Chem Inc., Downers Grove, IL), total
thyroxine (T4), total triiodothyronine (T3) (Alpha Diagnostic
International, San Antonio, TX), and growth hormone (Milli-
pore) levels were determined using commercially available
ELISA kits according to the manufacturers’ protocols. Plasma
fibroblast growth factor 21 (FGF21) (Phoenix Pharmaceuticals
Inc., Burlingame, CA) and glucagon (Millipore) were deter-
mined using RIA kits according to the manufacturers’ proto-
cols. Plasma creatine kinase was measured using an automatic
chemical analyzer (Johnson and Johnson VT250, Rochester,
NY) at the Animal Clinical Chemistry and Gene Expression
Facility, University of North Carolina, Chapel Hill. Plasma
TAG, glycerol (Sigma), and nonesterified fatty acids (NEFA)
(Wako, Richmond,VA)weremeasured colorimetrically per the
manufacturers’ instructions. Plasma glucose was measured
using a calibrated glucometer (One Touch Ultra).
Tissue Metabolites—Hepatic free glucose and glycogen were
measured using an adopted acid hydrolysis method (6). Liver
was collected from mice after a 4-h fast. Briefly, 40 mg of pul-
verized liver was homogenized in 1 ml of 1 N HCl. Half of the
homogenate was neutralized with 0.5 ml of 1 M NaOH (nonhy-
drolyzed group). The other half was incubated at 95 °C for 90
min before being neutralized with NaOH (hydrolyzed group).
Glucosyl units released in both groups were measured using a
colorimetrical glucose kit (Wako). The nonhydrolyzed group
represented the free glucosemeasurement, while the difference
between the hydrolyzed and the nonhydrolyzed groups repre-
sented the glycogen measurement. For bile acids and steroids,
liver and gonadal fat pads were collected from 5-week-oldmice
after a 4-h fast. Tissues were sent to Metabolon (Research Tri-
angle Park, NC), where the metabolites were measured using
gas chromatography/mass spectrometry (GC/MS) and liquid
chromatography/mass spectrometry (LC/MS) platforms as
described previously (7–10). Data were extracted and analyzed
by Metabolon (7–10). Briefly, raw data counts for each com-
pound were corrected for variation resulting from instrument
inter-day tuning differences and then rescaled to median equal
1. Data were expressed as fold change relative to wild type
controls.
Reverse Transcription-PCR—Total RNA was isolated from
tissue using RNeasymini kit (Qiagen, Valencia, CA), and cDNA
was synthesized using a high capacity cDNA reverse transcrip-
tion kit (Applied Biosystems, Carlsbad, CA). cDNA was ampli-
fied by real time PCR using SsoFast EvaGreen Supermix (Bio-
Rad) with primers specific to each gene of interest. Results were
normalized to the housekeeping genes and calculated relative
to the controls by the 2CT method.
Lipolysis—For in vivo lipolysis, mice were injected intraperi-
toneally with lipolytic stimuli (10 mg isoproterenol/1 kg BW or
1 mg CL316243/1 kg BW) (Sigma). Plasma was collected retro-
orbitally at base line and 1.5 h after injection. Plasma glycerol
(Sigma) and NEFA (Wako) were measured colorimetrically,
and glucose was measured using a glucometer (One Touch
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Ultra). Gonadal and inguinal adipose explants were used for ex
vivo lipolysis measurement as described previously (11, 12).
Briefly, pieces of fat explants (20mg)were incubated in 0.5ml of
Krebs Ringer Buffer (KRB) (12 mM HEPES, 121 mM NaCl, 4.9
mM KCl, 1.2 mM MgSO4, and 0.33 mM CaCl2) supplemented
with 3.5% fatty acid-free bovine serum albumin (FFF-BSA) and
0.1% glucose with or without 10 M isoproterenol at 37 °C.
Twenty five l of buffer was collected at various time points to
measure the release of glycerol colorimetrically (Sigma).
Adipocyte Isolation—Mature adipocytes were isolated from
gonadal or inguinal fat depots from 12–16 week-old mice and
used for incorporation and oxidation studies (13). Briefly,
gonadal or inguinal fat depots were removed under sterile con-
ditions, minced, and incubated at 37 °C with shaking for 1 h in
KRB supplemented with 1% FFF-BSA, 2.5 mM glucose, and 200
nM adenosine, containing 1 mg/ml collagenase I. The digested
tissueswere filtered through a sterile 250-mmesh andwashed
three times with supplemented KRB. Adipocytes were diluted
with supplemented KRB to reach 10% (by volume) adipocyte
solution and were maintained for 30 min in a polypropylene
tube before the start of the assay. Because of the small fat mass
in Bhmt/ mice, the same fat depots from two Bhmt/ mice
were pooled together to get enough adipocytes per sample.
Fatty Acid Incorporation and Oxidation—For fatty acid
incorporation into TAG, 500l of 10% adipocyte solution were
incubated with a 125-l reaction mixture containing 15 M
[1-14C]oleate (50 Ci/500 l; PerkinElmer Life Sciences) and
200 M unlabeled oleate complexed to BSA for 2 h at 37 °C.
[14C]TAGwas extracted (14), isolated by thin layer chromatog-
raphy, and detected and quantified with a Bioscan AR2000
Image System (Bioscan Inc., Washington, D. C.). The chroma-
toplate was developed in chloroform/methanol/ammonium
hydroxide (65:25:4; v/v/v) to 8 cm from the top. After the resid-
ual solvents evaporated, the plate was rerun in heptane/isopro-
pyl ether/acetic acid (60:40:4; v/v/v) to the top of the plate. For
oxidation, 250 l of 10% adipocytes solution were incubated
with a 125-l reaction mixture containing either 15 M
[1-14C]oleate and 200Munlabeled oleate or 4M [14C]glucose
(50Ci/500l; PerkinElmer Life Sciences) and 4mMunlabeled
glucose (in KRB) for 1.5 h at 37 °C. The reaction mixture was
incubated in a 13-ml polypropylene tube that contained a cen-
ter well filled with folded filter paper. The tube was sealed with
a rubber stopper. After 1.5 h of incubation, the reactionmixture
was acidified with 150 l of 70% perchloric acid, and 300 l of
1 M NaOH was added to the center well. The sealed tubes were
incubated at RT for an additional 45min. The center well (con-
taining [14C]CO2 trapped by base) was then collected and
placed into scintillation fluid (ScintiSafe 30% Mixture, Fisher)
and counted. The acidified reaction mixture (400 l) was
incubated overnight at 4 °C with 200 l of 20% BSA. The mix-
ture was centrifuged at 13,200 rpm for 20min, and an aliquot of
the supernatant was counted to determine 14C-labeled acid-
solublemetabolites (ASM). [14C]CO2 represents complete fatty
acid or glucose oxidation, and 14C-labeled ASM represents
incomplete fatty acid oxidation. For some experiments, 0.01
unit of insulin (Novo Nordisk Inc., Princeton, NJ) was added.
For hepatic FA oxidation experiments, fresh liver was excised,
minced, and homogenated in a buffer (250 mM sucrose, 1 mM
EDTA, 10 mM Tris-HCl, 2 mM ATP) to reach a 1:50 dilution.
Fortyl of liver homogenate was used tomeasure FA oxidation
as described above.
TissueHistology—Adipose tissueswere collected from7- and
12-week-old mice and fixed in 4% paraformaldehyde in 0.1 M
phosphate buffer for 24 h. Tissues were processed, paraffin-
embedded, sectioned at 5 m, and stained with hematoxylin
and eosin as described previously (15). For adipocyte size anal-
ysis, three images (200) per sample were taken, and the aver-
age adipocyte cell areas were analyzed using AxioVision 4.8
software (Zeiss).
Betaine Supplementation Study—7-Week-old Bhmt/
mice were fed either 0 or 5% betaine (Sigma)-supplemented
water for 2 weeks. Livers were collected for themeasurement of
Fgf21 expression as described above.
Statistics—Statistical differences were determined using
analysis of variance, Tukey-Kramer HSD, and Student’s t test
(JMP Version 6.0; SAS Institute, Cary, NC) and reported as
means  S.E. For the indirect calorimetry data analysis, the
total area under the curve was calculated per measure per
mouse using SAS. Statistical differences between the groups
were determined using Student’s t test (for mean comparison)
and Mann-Whitney test (for median comparison).
RESULTS
BHMTDeficiency Resulted in Reduced FatMass and Smaller
Adipocytes—We previously reported that Bhmt/ mice
gained less body weight between 5 and 9 weeks of age than did
their wild type littermates (p 0.05) (2). To determinewhether
the reduced weight gain of Bhmt/ mice was associated with
reduced fat or lean mass, we measured body composition of
these mice using MRI scan analysis. Bhmt/ mice had 20 and
30% less fat mass than did Bhmt/ mice at 7 and 14 weeks of
age, respectively (p  0.05), with no significant difference in
leanmass (Fig. 1A). The difference in fatmasswas confirmed by
collecting the individual fat pads. The two major white adipose
tissues (WAT), gonadal (GWAT) and inguinal (IWAT), of
Bhmt/ mice were significantly smaller than those of
Bhmt/mice at all ages (Fig. 1B). The disparity in fatmass was
exacerbated as mice aged, such that by 48 weeks of age,
Bhmt/ mice had a fat mass that was 41% that of Bhmt/
mice. To determine whether the reduced fat mass in Bhmt/
mice was due to fewer fat cells and/or smaller fat cells, the sizes
of individual adipocytes in GWAT and IWAT of Bhmt/ and
Bhmt/ mice were analyzed. Histological images showed that
bothGWATand IWAT fromBhmt/mice contained a larger
number of smaller adipocytes (Fig. 1C). We observed a 43%
reduction in adipocyte size in GWAT in both 7- and 12-week-
old Bhmt/ mice compared with those of Bhmt/ mice (p 
0.05) (Fig. 1D). We observed a 69% (p  0.05) and an 80% (p 
0.001) reduction in adipocyte size in IWAT in 7- and 12-week
old Bhmt/ mice, respectively, compared with those of
Bhmt/ mice (Fig. 1D). These data suggested that Bhmt/
mice likely had normal adipocyte differentiation and that the
Bhmt/ adipocytes either stored less and/or used more lipids
than did Bhmt/ adipocytes. Bhmt is predominantly ex-
pressed in rodent liver. Western blotting confirmed that
BHMT protein was specific to the liver and was absent in the
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adipose tissue frombothBhmt/ andBhmt/mice (Fig. 1E),
suggesting that the reduced fat mass in Bhmt/ mice was due
to an indirect effect of the lack of hepatic BHMT activity.
BHMT Deficiency Resulted in Enhanced Glucose Tolerance
and Insulin Sensitivity—Changes in adiposity are often associ-
ated with alterations in glucose and insulin homeostasis.
Bhmt/ mice had normal basal blood glucose levels (Fig. 1, F
and G). Upon intraperitoneal injection of either glucose (Fig.
1F) or insulin (Fig. 1G), Bhmt/ mice exhibited a faster glu-
cose removal rate than did wild type controls. Bhmt/ mice
also had a basal plasma insulin concentration that was 50% that
of the controls (p  0.05) (Table 2). These data indicated that
Bhmt/ mice had enhanced insulin sensitivity and glucose
tolerance.
Bhmt/ Mice Had Increased Energy Expenditure—To
investigate the mechanisms that elicit the reduced fat mass in
Bhmt/ mice, elements of energy metabolism, including food
intake, lipid uptake and absorption, body temperature, energy
expenditure and activity, were determined. Bhmt/ and
Bhmt/ mice consumed similar amounts of food per day (Fig.
2A). Fat load test (Fig. 2B) and fecal lipid content (Fig. 2C), tests
for lipid uptake and absorption, respectively, displayed no dif-
ferences between Bhmt/ and Bhmt/ mice. Bhmt/ and
Bhmt/ mice had similar rectal temperatures (Fig. 2D). Com-
pared with wild type controls, Bhmt/ mice had increased O2
consumption (Fig. 2E and Table 1) and increased CO2 release
(Fig. 2F) throughout the light and dark phases (Table 1), indi-
cating increased energy expenditure. Locomotor activity was
not increased in Bhmt/ mice (Fig. 2H), suggesting that the
increase in energy expenditurewas independent of activity. The
RER, an indicator of metabolic fuel preference, was not signifi-
cantly different betweenBhmt/ andBhmt/mice (Fig. 2G),
although there was a trend of increasing RER during the light
phase (p  0.053) (Table 1).
Thermogenesis Was Not Increased in Bhmt/ Mice—We
next investigated whether the reduced adiposity observed in
Bhmt/ mice was due to increased thermogenesis. We pre-
dicted that Bhmt/ mice would maintain a higher body tem-
perature during a cold challenge if they had increased thermo-
genesis. After 6 h of cold exposure, the wild type controls
dropped body temperature by 7.4% (from 38.18  0.14 °C to
35.36  0.07 °C), whereas Bhmt/ mice dropped body tem-
perature by 28.9% (from 37.92  0.09 °C to 26.98  2.15 °C)
(Fig. 3A). Mice were removed from the cold room when body
temperature was less than 28 °C. Brown adipose tissue (BAT) is
amajor site of nonshivering adaptive thermogenesis.We found
no significant difference in the morphology or the weight of
interscapular BATbetweenwild type and knock-outmice (data
not shown). Real time PCR analysis revealed normal thermo-
genic gene responses in Bhmt/ BAT tissue during cold expo-
sure, with elevated Pgc1 (peroxisome proliferator activated
receptor  coactivator), Lpl (lipoprotein lipase), Ucp1 (uncou-
pling protein 1), and Mcpt1 (muscle-type carnitine palmitoyl-
transferase 1) expression levels similar to those of Bhmt/
mice (Fig. 3B), indicating that adrenergic signaling was intact
and similar between genotypes. Bhmt/ and Bhmt/ mice
had similar BAT TAG concentration before and after cold
exposure, suggesting similar fuel storage and usage (Fig. 3C).
Mice were also able to maintain body temperature using exog-
enous fuels derived from organs, such as white adipose tissue
and liver via lipolysis and gluconeogenesis, and through adap-
tive thermogenesis involving shivering in skeletal muscle to
increase energy output. Upon cold exposure, Bhmt/ mice
had significantly lower plasma glucose (by 46%, p  0.01), glyc-
erol (by 46%, p  0.05), and NEFA (by 17%, p  0.05) concen-
trations compared with those of wild type controls (Fig. 3,
D–F), suggesting a restricted supply of exogenous fuels to
maintain a normal body temperature. Bhmt/ mice also had a
significantly elevated plasma creatine kinase activity (by 1.76-
fold, p  0.05), a marker for muscle breakdown, perhaps
because of increased shivering (Fig. 3G).
BHMT Deficiency Resulted in Altered Biochemical Measure-
ments in Plasma—Weexaminedwhether genotypic differences
in energy balance were accompanied by changes in plasma bio-
FIGURE 1. Bhmt/ mice had reduced adiposity and better insulin and
glucose sensitivities. A, body mass was measured in 7- and 14-week-old
Bhmt/ (black bar) and Bhmt/ (white bar) mice using magnetic resonance
images. *, p  0.05, different from Bhmt/ mice by Student’s t test; n  12
and 6 per group for 7- and 14-week-old mice respectively. B, two major fat
pads, GWAT and IWAT, were harvested from Bhmt/ (black square) and
Bhmt/ (white square) mice at various ages. *, p  0.01, different from
Bhmt/ of the same age by Student’s t test; n  10 –16 per group for 5–12-
week-old mice and n  5 per group for 20 – 48-week-old mice. C, morphology
of GWAT and IWAT from 12-week-old mice was shown by hematoxylin-eosin
staining. Scale bar, 50 m. D, adipocyte cell area of GWAT and IWAT from 7-
and 12-week-old Bhmt/ (black bar) and Bhmt/ (white bar) mice was ana-
lyzed using Zeiss AxioVision software. *, p  0.05; **, p  0.01, different from
Bhmt/ mice of the same age by Student’s t test; n  3–5 per group. E, BHMT
protein in liver and adipose tissue from Bhmt/ and Bhmt/ mice were
probed by Western blot analysis. The size of BHMT protein is 45 kDa. F and G,
glucose tolerance test (F) and insulin tolerance test (G) were performed in
7-week-old Bhmt/ (black square) and Bhmt/ (white square) mice via intra-
peritoneal injection of either glucose or insulin and measuring tail blood glu-
cose at various time points. *, p  0.05, different from Bhmt/ by Student’s t
test; n  7 per group. Data are presented as mean  S.E.
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chemicalmeasurements. Basal plasma glycerol, NEFA, and glu-
cose concentrations were similar for the two genotypes (Fig. 3,
D–F). Basal plasma insulin concentration was 50% lower in
Bhmt/ mice than in controls (p  0.05) (Table 2), suggesting
a better insulin sensitivity. Plasma growth hormone and gluca-
gon concentrations were not different between genotypes
(Table 2). Because of the prominent role of thyroid hormone in
controlling metabolic rate, we investigated whether increased
thyroid hormone concentration contributed to the hypermeta-
bolic phenotype inBhmt/mice. Indeed,Bhmt/mice had a
33% increase in plasma T4 (the major form of thyroid hormone
in blood) concentration compared with that of wild type con-
trols (p  0.05) (Table 2). Plasma T3 concentrations were not
different between genotypes. Concentration of fibroblast
growth factor 21 (FGF21), a recently discovered metabolic and
glucose regulator, was found to be 1.75-fold higher in Bhmt/
plasma than in Bhmt/ plasma (p  0.01) (Table 2). The
increase in plasma FGF21 concentration observed in Bhmt/
FIGURE 2. Bhmt/ mice had increased energy expenditure. A, food intake was measured in 7-week-old Bhmt/ (black bar) and Bhmt/ (white bar) mice
using an indirect calorimetry; n  8 per group. B, fat tolerance test was performed in 7-week-old Bhmt/ (black square) and Bhmt/ (white square) mice via
oral gavage of olive oil and measuring plasma TAG at various time points; n  3 per group. C, fecal fat from Bhmt/ (black bar) and Bhmt/ (white bar) mice
was extracted and measured using a colorimetric assay; n  7 per group. D, rectal temperature of 7-week-old Bhmt/ (black bar) and Bhmt/ (white bar) mice
was measured using a rectal probe thermometer at room temperature; n  6 –7 per group. E–H, oxygen consumption (E), carbon dioxide release (F), respiratory
exchange ratio (CO2 release/O2 used) (G), and locomotor activity (H) were measured in 7-week-old Bhmt
/ (black) and Bhmt/ (white) using an indirect
calorimetry. Data were obtained after mice being acclimated to the chambers for 24 h and adjusted to lean body mass; n  8 per group. Statistical analysis was
as shown in Table 1. Data are presented as mean  S.E. VO2, oxygen consumption; VCO2, carbon dioxide release.
TABLE 1
Indirect calorimetry data analysis
Oxygen consumption, carbon dioxide release, respiratory exchange ratio, and activity were measured in 7-week-old Bhmt/ and Bhmt/ mice using an indirect
calorimetry; n  8 per group. Data for light and dark cycles were obtained after mice were acclimated to the chambers for 24 h. VO2 and VCO2 were expressed based on
either the body weight or the lean bodymass (LBM). Area under the curve (AUC) on eachmeasure was analyzed followed by t test andMann-Whitney test. The unit of the
AUC isXmin, whereX is the unit for eachmeasure. Data are presented asmean S.E. VO2, oxygen consumption; VCO2, carbon dioxide release;MW test,Mann-Whitney
test.
Bhmt/ AUC Bhmt/ AUC t-test p value MW test p value Result
Light cycle
VO2 BW 2,336,800  18,620 2,677,403  78,771 0.003 0.0002 KO 	 WT
VO2 LBM 2,914,726  48,951 3,278,646  99,639 0.006 0.007 KO 	 WT
VCO2 BW 2,000,171  24,476 2,358,855  67,540 0.0008 0.0002 KO 	 WT
VCO2 LBM 2,494,090  38,538 2,888,922  87,258 0.002 0.0003 KO 	 WT
RER 584  6 600  4 0.053 0.13
Activity 1,007,037  86,738 1,020,225  173,692 0.95 0.69
Dark cycle
VO2 BW 2,789,262  52,593 3,207,252  62,912 0.0002 0.0002 KO 	 WT
VO2 LBM 3,477,415  66,509 3,927,978  86,540 0.001 0.0006 KO 	 WT
VCO2 BW 2,880,493  110,588 3,418,057  69,089 0.001 0.002 KO 	 WT
VCO2 LBM 3,582,632  103,277 4,183,744  83,270 0.0005 0.001 KO 	 WT
RER 720  17 746  10 0.21 0.16
Activity 3,376,383  421,560 2,351,641  235,179 0.06 0.07
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mice was accompanied by a 3.35-fold increase in Fgf21 expres-
sion in liver (where FGF21 is predominantly produced) com-
paredwith that ofBhmt/mice (p 0.05). Fgf21 expression is
regulated by factors such as Ppar (peroxisome proliferator
activated receptor-), Ppar (peroxisome proliferator acti-
vated receptor-), and Chrebp (carbohydrate response ele-
ment) (16–19). Hepatic gene expression analysis revealed that
Bhmt/mouse liver did not have altered expressions of Ppar
and Chrebp but had increased expressions of Ppar (by 3.5-
fold, p  0.05) as compared with the controls (Table 2).
BHMT Deficiency Resulted in Increased Bile Acids in Liver
and Adipose Tissue—A novel concept indicating a signaling
role of bile acids in the control of energy metabolism has
emerged (20, 21). Increasing bile acid pool size in mice
increased energy expenditure (21), while decreasing bile acid
pool size reduced energy expenditure, resulting in weight gain
and insulin resistance (20). BecauseBhmt/mice had reduced
plasma cholesterol (the precursor of bile acids) (2), we investi-
gated whether Bhmt deletion altered the concentrations of bile
acids. Cholic acid and chenodeoxycholic acid are the primary
bile acids and are often conjugated with taurine (as taurocho-
late or taurochenodeoxycholate) or glycine (as glycocholate or
glycochenodeoxycholate) forming bile salts. Compared with
wild type littermates, Bhmt deletion resulted in 9.50- and 3.41-
fold increases, respectively, in cholate (p  0.01) and taurocho-
late (p  0.05) in adipose tissue and in 2.33- and 1.62-fold
increases, respectively, in taurocholate (p  0.05) and glyco-
cholate (p 0.01) in liver (Table 3). Cholesterol is hydrolyzed to
form 7-hydroxycholesterol, the precursor of bile acids. Com-
paredwith the controls,Bhmt/mice had reduced cholesterol
(by 20%, p  0.05) and increased 7--hydroxycholesterol (by
2.98-fold, p  0.05) concentrations in the liver and increased
7--hydroxycholesterol (by 2.17-fold, p 0.01) concentrations
in the adipose tissue. These data suggest that Bhmt deletion
enhanced the synthesis of bile acids from cholesterol and that
the bile acids may contribute to the increased energy expendi-
ture observed in Bhmt/ mice.
Bhmt/ Mice Did Not Have Altered Lipolytic Rate—To
investigate whether themarkedly decreased adiposity observed
in Bhmt/ mice was due to increased lipolysis, we measured
lipolytic rates in both in vivo and ex vivomodels where lipolytic
stimuli were given, and glycerol released was measured as the
indicator of lipolytic rate. Plasma TAG and glucose were also
measured in the in vivo model to determine the whole body
response to adrenergic stimuli. During the in vivo experiment,
when CL316243 (3-adrenergic specific lipolytic stimulus) was
administered,Bhmt/ andBhmt/mice had similar levels of
plasma TAG, glycerol, and glucose release (Fig. 4, A–C). When
isoproterenol (nonspecific lipolytic stimulus) was adminis-
tered, Bhmt/ and Bhmt/ mice had similar levels of plasma
TAG and glycerol (Fig. 4, A and B) but had a 50% decreased
plasma glucose concentration compared with wild type con-
trols (p  0.05) (Fig. 4C), indicating a deficiency in hepatic
glucose storage or generation. Measurements of hepatic glu-
cose and glycogen concentrations revealed that Bhmt/ mice
had reduced hepatic glucose (by 22%, p  0.05) and glycogen
(by 17%, p  0.05) concentrations compared with those of
Bhmt/ mice (Table 2). These data perhaps explain why
Bhmt/ mice had lower plasma glucose concentration during
cold exposure and nonspecific lipolysis tests. Lipolysis was fur-
ther analyzed in isolated GWAT and IWAT explants from
Bhmt/ andBhmt/mice. The explants fromBhmt/mice
released similar amounts of glycerol as did those fromBhmt/
FIGURE 3. Bhmt/ mice were cold-sensitive due to lack of exogenous
fuels. Seven-week-old mice were exposed to room temperature or 4 °C, and
tissues collected after 6 h of exposure. A, body temperature of Bhmt/ (black
square) and Bhmt/ (white square) mice exposed to 4 °C was measured using
a rectal probe thermometer at different time points. *, p  0.05; **, p  0.01,
different from Bhmt/ mice at the same time point by Student’s t test; n 
13–14 per group. B, expression of genes involved in thermogenesis in the BAT
of Bhmt/ (black bar) and Bhmt/ (white bar) mice at room temperature
(n  3– 4 per group) or 4 °C (n  7– 8 per group) exposure. C, TAG in BAT from
room temperature (n  3– 6 per group) or 4 °C (n  13–14 per group) exposed
Bhmt/ (black bar) and Bhmt/ (white bar) mice were extracted and mea-
sured colorimetrically. D–G, plasma glucose (D), glycerol (E), NEFA (F), and
creatine kinase (CK) (G) from room temperature (n  3– 6 per group) or 4 °C
(n  13–14 per group) exposed Bhmt/ (black bar) and Bhmt/ (white bar)
mice were measured colorimetrically. *, p  0.05, different from Bhmt/
mice under the same condition by Student’s t test. Data are presented as
mean  S.E. BAT, brown adipose tissue; NEFA, nonesterified fatty acid; CK,
creatine kinase; PGC1, ppar coactivator 1; LPL, lipoprotein lipase; UCP1,
uncoupling protein 1; MCPT1, muscle carnitine palmitoyl transferase 1.
TABLE 2
Metabolites and gene expression in Bhmt/ and Bhmt/ plasma
and liver
Plasma and liver were collected from 7-week-old Bhmt/ and Bhmt/ mice after
4 h of fasting unless otherwise indicated. Plasma metabolites were measured using
commercially available kits; n 8–17 per group. Gene expression wasmeasured by
real time PCR, and expressed relatively to the controls; n 6–10 per group.Glucose
and glycogen were measured using an acid hydrolysis method; n  6 per group.
Organ Measurement Bhmt/ Bhmt/
Plasma Insulin (ng/ml) (7–12 weeks old) 0.806  0.120 0.405  0.157a
FGF21 (ng/ml) 1.49  0.16 2.6  0.3b
T4 (g/dl) 4.61  0.27 5.73  0.22b
T3 (ng/dl) 69.92  5.87 75.37  9.87
Growth hormone (ng/ml) 5.02  1.23 4.66  1.46
Glucagon (pg/ml) 39.68  2.22 39.79  1.08
Liver FGF21 expression (relative abundance) 1.00  0.24 3.35  0.95a
PPAR expression (relative abundance) 1.00  0.20 1.16  0.19
PPAR expression (relative abundance) 1.00  0.51 3.57  0.49a
ChREBP expression (relative abundance) 1.00  0.11 1.44  0.15
Glucose (mol/g liver) (5 weeks old) 23.22  0.91 18.22  1.47a
Glycogen (mol/g liver) (5 weeks old) 100.13  7.01 83.13  4.21a
a p  0.05.
b p  0.01, different from Bhmt/ by Students’ t test. Data are presented as
mean  S.E.
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mice under basal or stimulated conditions (Fig. 4, D and E),
suggesting normal lipolytic machinery in Bhmt/ mice.
BHMT Deficiency Resulted in Impaired TAG Synthesis and
Enhanced Glucose Oxidation in Isolated Mature Adipocytes
and Impaired TAG Oxidation in Liver Homogenates—Because
TAG breakdown was not defective, we assessed whether TAG
synthesis and FA oxidation were altered within the fat cells.We
isolated mature adipocytes from both GWAT and IWAT from
Bhmt/ mice and their littermate controls and measured the
rates of [1-14C]oleate incorporation into TAG (for TAG syn-
thesis), into CO2 (for complete FA oxidation) and acid-soluble
metabolites (for incomplete FA oxidation). Mature adipocytes
isolated fromBhmt/ andBhmt/GWAThad the same rate
of TAG synthesis (Fig. 5A). Interestingly, mature adipocytes
isolated from Bhmt/ IWAT made less TAG (by 62%) com-
pared with that of Bhmt/ mice (p  0.001). GWAT and
IWAT adipocytes from Bhmt/ and Bhmt/ mice had the
sameFAoxidation rate (Fig. 5B), indicating normal-oxidation
machinery. Because several lines of evidence (enhanced glucose
tolerance and insulin sensitivity, reduced glucose upon cold
exposure and isoproterenol stimulus, and reduced hepatic glu-
cose storage) suggested an increased reliance on glucose in
Bhmt/ mice, we assessed whether their mature adipocytes
usedmore glucose. At basal level (without insulin), mature adi-
pocytes isolated from Bhmt/ and Bhmt/ GWAT had the
same glucose oxidation rate (Fig. 5C). However, with insulin
treatment, Bhmt/ GWAT oxidized 2.38-fold more glucose
than did Bhmt/ GWAT (p  0.05). Mature adipocytes iso-
lated from Bhmt/ IWAT oxidized 2.4- and 1.78-fold more
glucose than did Bhmt/ IWAT without and with insulin
treatment (p  0.01) (Fig. 5D). Compared with the basal level,
insulin treatment induced glucose oxidation by 1.87-, 4.17-,
3.21-, and 3.79-fold, respectively, for Bhmt/ GWAT,
Bhmt/ GWAT, Bhmt/ IWAT, and Bhmt/ IWAT, con-
firming the viability of the isolatedmature adipocytes, and indi-
cating a higher response to insulin in Bhmt/ mice, particu-
larly in GWAT (Fig. 5, C and D). Because Bhmt/ mice had
fatty liver (2), we also investigated the possibility that Bhmt
deficiency might lead to impaired hepatic fatty acid oxidation.
FA oxidation rate was determined using liver homogenates
from Bhmt/ and Bhmt/ mice. Bhmt/ mouse liver
released 60% less CO2 than did Bhmt/ mouse liver, suggest-
ing impaired complete FA oxidation (p 0.03) (Fig. 5, E and F).
Betaine Supplementation IncreasedHepatic Fgf21 Expression—
Betaine is commonly used in the livestock and poultry indus-
tries to generate leaner meats (22), and FGF21 is a novel meta-
bolic regulator (23). Bhmt ablation resulted in a significant
accumulation of betaine in many tissues (2), and in increased
hepatic Fgf21 expression as well as circulating FGF21 protein
(Table 2). To investigate the potential interaction between
TABLE 3
Bile acids and sterols in Bhmt/ and Bhmt/ liver and adipose tissue
Liver and gonadal adipose tissue were collected from 5-week-old Bhmt/ and Bhmt/ mice after 4 h of fasting; n  6 per group. The amount and the relative abundance
of metabolites were measured and analyzed by liquid and gas chromatography by mass spectrometry. Data are presented as mean  S.E.
Metabolites Bhmt/ mean counts Bhmt/ mean counts -Fold change p value Result
Liver
Cholate 0.84  0.08 2.26  0.78 2.71 0.184
Taurocholate 0.75  0.09 1.21  0.12 1.62 0.010 KO 	 WT
Glycocholate 0.88  0.18 1.95  0.43 2.33 0.021 KO 	 WT
Taurochenodeoxycholate 1.62  0.44 0.88  0.22 0.54 0.228
Cholesterol 1.19  0.07 0.95  0.06 0.80 0.036 WT 	 KO
7--Hydroxycholesterol 0.76  0.45 2.26  0.71 2.98 0.020 KO 	 WT
Adipose
Cholate 0.94  0.23 8.93  2.88 9.50 0.005 KO 	 WT
Taurocholate 1.14  0.31 3.90  0.96 3.41 0.020 KO 	 WT
Cholesterol 1.09  0.08 1.25  0.10 1.15 0.261
7--hydroxycholesterol 0.88  0.19 1.92  0.20 2.17 0.009 KO 	 WT
7--hydroxycholesterol 1.03  0.18 1.53  0.21 1.48 0.075
FIGURE 4. Bhmt/ mice had normal lipolytic responses. A–C, plasma TAG (A), glycerol (B), and glucose (C) were measured in 7-week-old Bhmt/ (black bar)
and Bhmt/ (white bar) mice before and after i.p. injection of lipolytic stimulus isoproterenol or CL316243; n  5–7 per group. D and E, gonadal (D) or inguinal
(E) explants from Bhmt/ (black square) and Bhmt/ (white square) mice were used to measure glycerol release without (solid line) or with (dashed line) 10 M
lipolytic stimulus isoproterenol; n  4 – 6 per group. Data are presented as mean  S.E. Iso, isoproterenol; CL, CL CL316243.
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betaine and FGF21, wild type mice were fed either 0 or 5%
betaine supplemented water for 2 weeks. A 5% betaine supple-
mented water was selected based on our experience, that this
concentration did not alter food or water intake in mice (data
not shown). Interestingly, at 2 weeks, 5% betaine water feeding
increased Fgf21 expression by almost 7-fold in wild type liver
(p  0.05) (Fig. 6).
DISCUSSION
BHMT is one of the most abundant proteins in the liver,
representing 0.6–1.6% of the total protein (24). However, its
known functions are limited to its roles in choline and one-
carbonmetabolism. Our current studies establish a unique role
for BHMT in energy homeostasis.
Previously, we found that Bhmt/ mice had reduced body
weight from 5 to 9 weeks of age compared with wild type litter-
mates, although the difference in bodyweight disappeared after
9 weeks (2). MRI and dissection of fat pads revealed that the
reduced body weight in Bhmt/ mice was due to lower fat
mass. Bhmt/ mice had smaller fat pad mass that persisted
through at least 1 year of age compared with the controls.
Bhmt/ mice were able tomaintain bodyweight in light of the
reduced fat mass after 9 weeks of age perhaps because they had
heavier livers that made up for the difference in fat mass weight
(2). For example, at 12 weeks of age, Bhmt/ mice had an
average liver weight 409mg heavier than that of Bhmt/ mice
(1.85 0.08 g inBhmt/mice versus 1.44 0.06 g inBhmt/
mice), which made up for the difference in fat pad mass (511 
39mg in Bhmt/ mice versus 815  74mg in Bhmt/ mice).
BHMT is a liver-specific enzyme in rodents (1). Because BHMT
protein was absent in normal adipose tissue, this observation
indicated that the reduced fatmass inBhmt/micewas due to
an indirect effect of the lack of hepatic BHMT activity. How
could lack of an hepatic enzyme result in reduced fatmass?One
possibility is diminished lipid transport from the liver to adi-
pose tissue via very low density lipoprotein (VLDL). Our previ-
ous work showed that Bhmt/ mice had reduced hepatic
PtdCho concentration, resulting in decreased VLDL secretion
and increased hepatic fat accumulation (2). However, the
amount of fat missing in fat pads exceeds the excess amount of
fat accumulated in the liver. In addition, adipose should be able
to store lipid obtained from the diet instead of depending solely
on hepatic lipid sources. Thus, decreased VLDL secretion is
unlikely to account for all the fat absence. Homeostasis of
energy stores is regulated by mechanisms that include modula-
tion ofmetabolic rate and thermogenesis, control ofmetabolite
fluxes among various organs, and modulation of fuel synthesis
and usage within adipose tissue. Examination of each of these
parameters in Bhmt/ mice showed that multiple factors
might contribute to the reduced adiposity observed in this
mouse model.
Compared with the controls, Bhmt/ mice had better glu-
cose tolerance and insulin sensitivity. Glucose concentrations
measured after a 4-h fast were about 200 mg/dl for both
Bhmt/ and Bhmt/ mice. Glucose concentrations mea-
sured after a 16-h fast were higher in Bhmt/ (158  6 mg/dl)
than in Bhmt/ mice (119  10 mg/dl, p  0.05). Glucose
values were at the high end of what have been reported for
C57Bl mice (130–218 mg/dl for a 4-h fast (25–29) and 90–120
mg/dl for a 12–16 h fast (27, 30)).
Bhmt/ mice had normal food intake, fat clearance rate,
and fecal fat content, indicating that the reduced adiposity was
not due to reduced energy intake or fat malabsorption.
Bhmt/mice had increased rates ofO2 consumption andCO2
FIGURE 5. Bhmt/ mouse adipocytes had altered TAG synthesis and glu-
cose oxidation. A, mature adipocytes were isolated from Bhmt/ (black bar)
and Bhmt/ (white bar) mice GWAT and IWAT and used to determine the rate
of labeled fatty acid incorporated to triacylglycerol. **, p  0.01, different
from Bhmt/ mice by Student’s t test; n  4 –5 per group. B, mature adi-
pocytes were isolated from Bhmt/ and Bhmt/ mice GWAT and IWAT and
used to determine the rate of 14C 18:1 oxidation: CO2 (gray bar), ASM (white
bar); n  10 –13 per group. C and D, mature adipocytes were isolated from
Bhmt/ (black bar) and Bhmt/ (white bar) mice GWAT (C) and IWAT (D) and
used to determine the rate of glucose oxidation with or without insulin. *, p 
0.05; **, p  0.01 different from Bhmt/ mice under the same treatment by
Student’s t test; n  7–10 per group without insulin, n  4 –7 per group with
insulin. E and F, liver homogenates from Bhmt/ (black bar) and Bhmt/
(white bar) mice were used to determine the rate of 14C 18:1 oxidation. *, p 
0.05, different from Bhmt/ mice by Student’s t test n  5–7 per group Data
are presented as mean  S.E.
FIGURE 6. Betaine supplementation increased hepatic Fgf21 expression.
7-Week-old Bhmt/ mice were fed either a 0 or a 5% betaine supplemented
water for 2 weeks. Livers were collected for the measurement of Fgf21 expres-
sion using real time PCR. Expression was expressed relatively to the controls;
n  6 – 8 per group. *, p  0.05, different from 0% group by Student’s t test.
Data are presented as mean  S.E.
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release, suggesting that the reduced fat mass was partially due
to increased energy utilization. Because locomotor activity did
not differ between genotypes, the increased energy expenditure
exhibited by Bhmt/ mice was not due to increased physical
activity. We investigated whether the reduced adiposity was
due to increased thermogenesis. Upon cold exposure,Bhmt/
mice failed to maintain their body temperature. Bhmt/ mice
exhibited normal induction of genes involved in mitochondrial
biogenesis, uncoupling, and fatty acid oxidation in BAT. Fur-
thermore, Bhmt/ mice had normal BAT TAG storage and
functional lipolytic machinery in peripheral tissues. However,
during prolonged cold exposure, Bhmt/ mice had lower
plasma glucose, glycerol, andNEFA and higher plasma creatine
kinase (marker of muscle breakdown). These data indicated
that Bhmt/ mice were not hyperthermogenic. In fact, these
animals were cold-sensitive due to lack of exogenous fuel and
had to depend on shivering thermogenesis in an attempt to
maintain body temperature. The reduced plasma glucose con-
centration inBhmt/mice during cold exposurewas probably
because they had less hepatic glucose stored. The reduced
plasma glycerol and NEFA concentrations in Bhmt/ mice
during cold exposure were probably because they had less TAG
stored in the adipose tissue to be released during energy needs.
It was also possible that theBhmt/ mouse liver was taking up
glycerol more efficiently than did Bhmt/ for glucose synthe-
sis to make up for the lack of hepatic glucose.
Within the adipose tissue, we observed thatBhmt/ IWAT,
but not GWAT, made 62% less TAG than did the controls.
AlthoughBhmt/mice had normal lipolytic and FAoxidation
machinery in both fat depots, the mice might have less TAG
stored at a time when fuel was needed. We suspected that
Bhmt/ micemight utilize more glucose instead of FA as fuel.
Indeed, we observed increased glucose oxidation in Bhmt/
GWAT with insulin stimulus, and increased glucose oxidation
in Bhmt/ IWAT with or without insulin stimulus. This
hypothesis was further supported by the enhanced glucose tol-
erance and insulin sensitivity observed in Bhmt/ mice, the
reduced plasma glucose during cold exposure, -adrenergic
stimulation, 16 h of fasting, and the reduced hepatic glucose
storage. Enhanced glucose oxidation in adipose tissue and
reduced hepatic glucose storage could potentially limit the
availability of acetyl-CoA for forming fatty acids and the avail-
ability of the glycerol backbone for forming TAG, contributing
to reduced adiposity. These data also suggested that the altered
fuel metabolism in Bhmt/ mice was not limited to adipose
tissue but also occurred in the liver. Bhmt/ mice had fatty
liver and lower hepatic glucose concentrations, suggesting the
possibility of FA utilization impairment. Indeed, we found
Bhmt/ mouse liver burned less FA as compared with
Bhmt/ mouse liver.
It is intriguing that the observed effects were more pro-
nounced in IWAT as compared with GWAT in Bhmt/ mice.
The size of 12-week-old Bhmt/ GWAT adipocytes was 57%
that of controls, although IWAT adipocytes size was 20% the
size of that in controls. Adipocytes from Bhmt/ IWAT syn-
thesized 62% less TAG and oxidized 2.4-foldmore glucose than
did control IWAT, although no changes were detected in adi-
pocytes from GWAT. It is commonly accepted that visceral
(GWAT) and subcutaneous (IWAT) fat pads are different.
GWAT is considered to be the “pure WAT,” whereas IWAT is
a “convertibleWAT” that may convert to BAT (31). Compared
with visceral fat, subcutaneous fat cells express more thyroid
hormone receptors (32) and mitochondrialUcp1 (33, 34), have
more efficient insulin signaling and Glut4 (35), and are more
responsive to Ppar thiazolidinedione ligand (36, 37). When
subcutaneous fat was transplanted into the visceral cavity of
mice, it reduced bodyweight and fatmass and enhanced insulin
and glucose sensitivities (38), suggesting an intrinsic difference
between the two fat pads. These differences in GWAT and
IWAT may explain why effects in Bhmt/ IWAT are more
pronounced. Other investigators also report metabolic differ-
ences between GWAT and IWAT (39).
Bhmt/ mice had reduced adiposity due to increased
energy expenditure, enhanced glucose oxidation in WAT, and
reduced TAG synthesis in WAT. The next question was how
Bhmtdeficiency could exert these differences, andwe identified
several candidate mechanisms that may be responsible. Coin-
ciding with increased energy expenditure, Bhmt/ mice had
elevated plasma T4 (the major form of thyroid hormone in the
blood), a well known energymetabolism regulator. PlasmaT4 is
converted to T3, the active form of thyroid hormone, with tis-
sues. Unfortunately, we were unable tomeasure the conversion
of T4 toT3 andT3 concentrationwithin tissues. Another poten-
tial candidate that may be responsible for these metabolic
changes in Bhmt/ mice is FGF21. Bhmt/ mice overex-
pressed hepatic Fgf21 and had elevated plasma FGF21 concen-
tration. FGF21 is a novel metabolic regulator that is preferen-
tially expressed in the liver (23). FGF21 increases glucose
uptake (40, 41) and decreases intracellular TAG content in
adipocytes (40); it lowers plasma glucose and TAG when
administered to diabetic mice (41); and it increases energy
expenditure and improves insulin sensitivity in diet-induced
obese mice (42, 43). Another potential candidate is bile acid.
Recent studies suggested a role of bile acids in glucose and
energy homeostasis. Mice fed a cholic acid (a bile acid)-sup-
plemented diet had increased energy expenditure, prevent-
ing obesity and insulin resistance (21), although mice with
reduced bile acids had decreased energy expenditure (20).
Bhmt deletion resulted in increased cholate and taurocho-
late in adipose tissue and in increased taurocholate and gly-
cocholate in liver. Bhmt/ mice had reduced hepatic and
serum cholesterol (2). This was perhaps due to an increased
conversion of cholesterol to cholic acid. Indeed, the concen-
tration of 7-hydroxycholesterol, the precursor to bile acid
from cholesterol, was significantly elevated in both liver and
adipose in Bhmt/ mice.
Thyroid hormone, FGF21, and bile acids all induce similar
metabolic changes and were all altered in Bhmt/ mice. In
fact, a growing body of evidence suggests an interaction among
bile acids, thyroid hormone, and FGF21. Thyroid hormone
induced cholesterol 7-hydroxylase (CYP7A1), the rate-limit-
ing enzyme in bile acid synthesis from cholesterol (44, 45), and
there was an inverse relationship between thyroid hormone
level and serum cholesterol (46). Thyroid hormone also
induced hepatic Fgf21 expression in mice (47). Bile acids
enhanced the conversion of T4 to T3 within tissues, resulting in
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increased energy expenditure in mice (21). Both bile acids and
FGF21 concentrations were elevated in patients with nonalco-
holic fatty liver (48). These studies suggest an interaction
among these factors and Bhmt deficiency, resulting in reduced
adiposity observed in Bhmt/ mice.
Aside from the increased bile acids, thyroid hormone, and
FGF21, deletion of hepatic Bhmtmay cause reduced adipos-
ity via changes in choline metabolites. As mentioned previ-
ously, BHMT is a major regulator of choline metabolism.
Deletion of Bhmt resulted in altered choline metabolites,
including a 21- and 2-fold increase in hepatic and adipose
tissue betaine concentrations and an 82 and 53% decrease in
hepatic and adipose tissue choline concentrations (2).
Recently, studies suggested that manipulation of dietary
choline or alteration of pathways in choline metabolism may
influence energy expenditure and adiposity. Mice fed a
methionine- and choline-deficient diet were hypermeta-
bolic, lost weight (49), and had better insulin sensitivity and
glucose tolerance (50). Mice with the Pemt gene (making
PtdCho from phosphatidylethanolamine) deleted had nor-
mal metabolic parameters on a regular chow diet compared
with wild type controls; however, when fed a high fat diet,
they had increased oxygen consumption and RER, accumu-
lated less body fat, and had increased glucose sensitivity (51).
The lack of weight gain in Pemt/ mice disappeared when
mice were supplemented with choline. These observations
suggest a potential role of choline in modulating energy
metabolism. Similar to methionine- and choline-deficient
diet fed mice and the Pemt/ mice, Bhmt/ mice had
reduced choline and PtdCho concentrations, enhanced glu-
cose and insulin sensitivities, increased energy expenditure,
and reduced adiposity.
Bhmt ablation also resulted in a significant accumulation of
betaine, which serves as a methyl donor and osmolyte. Betaine
is commercially available as a feed additive; it is widely dis-
cussed as a “carcass modifier” because of its lipotropic and
growth-promoting effects, generating leanermeat (22). Dietary
betaine supplementation resulted in reduced abdominal fat in
poultry and reduced carcass fat (by 10–18%) in pigs (22). The
exact mechanism by which betainemodulates carcass quality is
still unclear but has been suggested to involve interactions of
betaine with growth factors and thyroid hormones (52–60).
We did not observe increased growth hormone but did observe
enhanced plasma T4 and FGF21 concentrations and conse-
quently hypermetabolism in Bhmt/ mice. Betaine may also
have a role as a glucose sensitizer. Betaine supplementation
enhanced insulin sensitivity in diet-induced obese mice and
increased insulin signaling pathway in isolated adipocytes (61).
We found that 2 weeks of 5% betaine feeding increased Fgf21
expression by 7-fold in wild type liver. How betaine increases
Fgf21 expression and whether FGF21 is responsible for the
reduced adiposity phenotype in Bhmt/ mice warrant more
studies.
To summarize (Fig. 7), Bhmt deletion resulted in reduced
adiposity, enhanced insulin sensitivity, and glucose tolerance.
The reduction in fat mass in Bhmt-deficient mice could be
attributed to increased whole body energy expenditure,
decreased mobilization of lipids from the liver (VLDL) to be
stored in adipose tissues, decreased TAG synthesis in white
adipose tissue, and increased glucose oxidation in white adi-
pose tissue. Deletion of Bhmt resulted in a variety of biochem-
ical abnormalities, including elevated thyroid hormone, bile
salts, FGF21 and betaine concentrations, and reduced choline
and PtdCho concentrations. Many of these changes have been
related to elevated energy metabolism, reduced adiposity, and
enhanced glucose tolerance and insulin sensitivity. How these
parameters interact with each other warrants further studies.
This study suggests a role of Bhmt in regulating energy metab-
olism and adiposity.
FIGURE 7. Overview of metabolic disturbances in Bhmt/ mice. Increased energy expenditure, decreased lipid mobilization from the liver to adipose tissue,
decreased TAG synthesis, and enhanced glucose oxidation together resulted in reduced fat mass in Bhmt/ mice. Bhmt deletion increased plasma FGF21 and
T4 concentrations and increased betaine and bile acids concentrations while decreased choline concentration in both liver and adipose tissue. All of these
changes had been associated with increased energy expenditure, enhanced insulin sensitivity, and reduced adiposity, and might be interrelated with one
another. BHMT, betaine-homocysteine S-methyltransferase; Cho, choline; Bet, betaine; FGF21, fibroblast growth factor 21; Chol, cholesterol; 7 hydroxychol,
7-hydroxycholesterol; BAs, bile acids; Glu, glucose; Gly, glycogen; G-6-P, glucose 6-phosphate.
BHMT and Adiposity
16196 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 20 • MAY 11, 2012
REFERENCES
1. Szegedi, S. S., Castro, C. C., Koutmos, M., and Garrow, T. A. (2008) Be-
taine-homocysteine S-methyltransferase-2 is an S-methylmethionine-
homocysteine methyltransferase. J. Biol. Chem. 283, 8939–8945
2. Teng, Y. W., Mehedint, M. G., Garrow, T. A., and Zeisel, S. H. (2011)
Deletion of betaine-homocysteine S-methyltransferase in mice perturbs
choline and 1-carbonmetabolism, resulting in fatty liver and hepatocellu-
lar carcinomas. J. Biol. Chem. 286, 36258–36267
3. Ji, C., Shinohara, M., Vance, D., Than, T. A., Ookhtens, M., Chan, C., and
Kaplowitz, N. (2008) Effect of transgenic extrahepatic expression of be-
taine-homocysteine methyltransferase on alcohol or homocysteine-in-
duced fatty liver. Alcohol. Clin Exp. Res. 32, 1049–1058
4. Delgado-Reyes, C. V., Wallig, M. A., and Garrow, T. A. (2001) Immuno-
histochemical detection of betaine-homocysteine S-methyltransferase in
human, pig, and rat liver and kidney. Arch. Biochem. Biophys. 393,
184–186
5. Folch, J., Lees, M., and Sloane Stanley, G. H. (1957) A simple method for
the isolation and purification of total lipids from animal tissues. J. Biol.
Chem. 226, 497–509
6. Passonneau, J. V., and Lauderdale, V. R. (1974) A comparison of three
methods of glycogenmeasurement in tissues.Anal. Biochem. 60, 405–412
7. Boudonck, K. J., Mitchell, M. W., Német, L., Keresztes, L., Nyska, A.,
Shinar, D., and Rosenstock, M. (2009) Discovery of metabolomics bio-
markers for early detection of nephrotoxicity. Toxicol. Pathol. 37,
280–292
8. Evans, A. M., DeHaven, C. D., Barrett, T., Mitchell, M., and Milgram, E.
(2009) Integrated, nontargeted ultrahigh performance liquid chromatog-
raphy/electrospray ionization tandemmass spectrometry platform for the
identification and relative quantification of the small molecule comple-
ment of biological systems. Anal. Chem. 81, 6656–6667
9. Lawton, K. A., Berger, A., Mitchell, M., Milgram, K. E., Evans, A. M., Guo,
L., Hanson, R. W., Kalhan, S. C., Ryals, J. A., and Milburn, M. V. (2008)
Analysis of the adult human plasma metabolome. Pharmacogenomics 9,
383–397
10. Barrett, T., Dehaven, C. D., and Alexander, D. C. (October 27, 2008) U. S.
Patent 7,433,787
11. Jaworski, K., Ahmadian,M., Duncan, R. E., Sarkadi-Nagy, E., Varady, K.A.,
Hellerstein, M. K., Lee, H. Y., Samuel, V. T., Shulman, G. I., Kim, K. H., de
Val, S., Kang, C., and Sul, H. S. (2009) AdPLA ablation increases lipolysis
and prevents obesity induced by high fat feeding or leptin deficiency.Nat.
Med. 15, 159–168
12. Warne, J. P., John, C.D., Christian,H.C.,Morris, J. F., Flower, R. J., Sugden,
D., Solito, E., Gillies, G. E., and Buckingham, J. C. (2006) Gene deletion
reveals roles for annexin A1 in the regulation of lipolysis and IL-6 release
in epididymal adipose tissue. Am. J. Physiol. Endocrinol. Metab. 291,
E1264–E1273
13. Viswanadha, S., and Londos, C. (2006) Optimized conditions for mea-
suring lipolysis in murine primary adipocytes. J. Lipid Res. 47, 1859–1864
14. Bligh, E. G., and Dyer,W. J. (1959) A rapidmethod of total lipid extraction
and purification. Can. J. Biochem. Physiol. 37, 911–917
15. Lillie, R. (1965)Histopathologic Technic and Practical Histochemistry, 3rd
Ed., pp. 1–715, McGraw-Hill Book Co., New York
16. Moyers, J. S., Shiyanova, T. L., Mehrbod, F., Dunbar, J. D., Noblitt, T. W.,
Otto, K. A., Reifel-Miller, A., and Kharitonenkov, A. (2007) Molecular
determinants of FGF-21 activity-synergy and cross-talk with PPAR sig-
naling. J. Cell. Physiol. 210, 1–6
17. Oishi, K., andTomita, T. (2011) Thiazolidinediones are potent inducers of
fibroblast growth factor 21 expression in the liver. Biol. Pharm. Bull. 34,
1120–1121
18. Iizuka, K., Takeda, J., and Horikawa, Y. (2009) Glucose induces FGF21
mRNA expression through ChREBP activation in rat hepatocytes. FEBS
Lett. 583, 2882–2886
19. Sánchez, J., Palou, A., and Picó, C. (2009) Response to carbohydrate and fat
refeeding in the expression of genes involved in nutrient partitioning and
metabolism: striking effects on fibroblast growth factor-21 induction. En-
docrinology 150, 5341–5350
20. Watanabe, M., Horai, Y., Houten, S. M., Morimoto, K., Sugizaki, T., Arita,
E., Mataki, C., Sato, H., Tanigawara, Y., Schoonjans, K., Itoh, H., and Au-
werx, J. (2011) Lowering bile acid pool size with a synthetic farnesoid X
receptor (FXR) agonist induces obesity and diabetes through reduced en-
ergy expenditure. J. Biol. Chem. 286, 26913–26920
21. Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim,
B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T.,
Schoonjans, K., Bianco, A. C., and Auwerx, J. (2006) Bile acids induce
energy expenditure by promoting intracellular thyroid hormone activa-
tion. Nature 439, 484–489
22. Eklund, M., Bauer, E., Wamatu, J., and Mosenthin, R. (2005) Potential
nutritional and physiological functions of betaine in livestock. Nutr. Res.
Rev. 18, 31–48
23. Nishimura, T., Nakatake, Y., Konishi, M., and Itoh, N. (2000) Identifica-
tion of a novel FGF, FGF-21, preferentially expressed in the liver. Biochim.
Biophys. Acta 1492, 203–206
24. Pajares, M. A., and Pérez-Sala, D. (2006) Betaine-homocysteine S-meth-
yltransferase. Just a regulator of homocysteinemetabolism?Cell. Mol. Life
Sci. 63, 2792–2803
25. Rajala,M.W.,Qi, Y., Patel, H. R., Takahashi, N., Banerjee, R., Pajvani, U. B.,
Sinha, M. K., Gingerich, R. L., Scherer, P. E., and Ahima, R. S. (2004)
Regulation of resistin expression and circulating levels in obesity, diabetes,
and fasting. Diabetes 53, 1671–1679
26. Ellis, J.M.,Mentock, S.M., Depetrillo,M.A., Koves, T. R., Sen, S.,Watkins,
S. M., Muoio, D. M., Cline, G. W., Taegtmeyer, H., Shulman, G. I., Willis,
M. S., and Coleman, R. A. (2011)Mouse cardiac acyl-coenzyme A synthe-
tase 1 deficiency impairs fatty acid oxidation and induces cardiac hyper-
trophy.Mol. Cell. Biol. 31, 1252–1262
27. Li, L. O., Ellis, J. M., Paich, H. A., Wang, S., Gong, N., Altshuller, G.,
Thresher, R. J., Koves, T. R., Watkins, S. M., Muoio, D. M., Cline, G. W.,
Shulman, G. I., and Coleman, R. A. (2009) Liver-specific loss of long chain
acyl-CoA synthetase-1 decreases triacylglycerol synthesis and -oxida-
tion and alters phospholipid fatty acid composition. J. Biol. Chem. 284,
27816–27826
28. Reaven, P., Merat, S., Casanada, F., Sutphin, M., and Palinski, W. (1997)
Effect of streptozotocin-induced hyperglycemia on lipid profiles, forma-
tion of advanced glycation end products in lesions, and extent of athero-
sclerosis in LDL receptor-deficient mice.Arterioscler. Thromb. Vasc. Biol.
17, 2250–2256
29. Naggert, J., Svenson, K. L., Smith, R. V., Paigen, B., and Peters, L. L. (2012)
Diet Effects on Bone Density and Content, Body Composition, and Plasma
Glucose, Leptin, and Insulin Levels in 43 Inbred Strains of Mice on a High
Fat Atherogenic Site. The Jackson Laboratory, Bar Harbor, ME
30. Le Lay, J., Tuteja, G., White, P., Dhir, R., Ahima, R., and Kaestner, K. H.
(2009) CRTC2 (TORC2) contributes to the transcriptional response to
fasting in the liver but is not required for the maintenance of glucose
homeostasis. Cell Metab. 10, 55–62
31. Loncar, D. (1991) Convertible adipose tissue in mice.Cell Tissue Res. 266,
149–161
32. Ortega, F. J., Moreno-Navarrete, J. M., Ribas, V., Esteve, E., Rodriguez-
Hermosa, J. I., Ruiz, B., Peral, B., Ricart, W., Zorzano, A., and Fernández-
Real, J. M. (2009) Subcutaneous fat shows higher thyroid hormone recep-
tor-alpha1 gene expression than omental fat. Obesity 17, 2134–2141
33. Rossmeisl, M., Barbatelli, G., Flachs, P., Brauner, P., Zingaretti, M. C.,
Marelli, M., Janovská, P., Horáková, M., Syrový, I., Cinti, S., and Kopecký,
J. (2002) Expression of the uncoupling protein 1 from the aP2 gene pro-
moter stimulates mitochondrial biogenesis in unilocular adipocytes in
vivo. Eur. J. Biochem. 269, 19–28
34. Kopecky, J., Clarke, G., Enerbäck, S., Spiegelman, B., and Kozak, L. P.
(1995) Expression of the mitochondrial uncoupling protein gene from the
aP2 gene promoter prevents genetic obesity. J. Clin. Invest. 96, 2914–2923
35. Lefebvre, A. M., Laville, M., Vega, N., Riou, J. P., van Gaal, L., Auwerx, J.,
and Vidal, H. (1998) Depot-specific differences in adipose tissue gene
expression in lean and obese subjects. Diabetes 47, 98–103
36. Sewter, C. P., Blows, F., Vidal-Puig, A., and O’Rahilly, S. (2002) Regional
differences in the response of human pre-adipocytes to PPAR and RXR
agonists. Diabetes 51, 718–723
37. Adams, M., Montague, C. T., Prins, J. B., Holder, J. C., Smith, S. A., Sand-
ers, L., Digby, J. E., Sewter, C. P., Lazar, M. A., Chatterjee, V. K., and
BHMT and Adiposity
MAY 11, 2012 • VOLUME 287 • NUMBER 20 JOURNAL OF BIOLOGICAL CHEMISTRY 16197
O’Rahilly, S. (1997)Activators of peroxisome proliferator-activated recep-
tor  have depot-specific effects on human preadipocyte differentiation.
J. Clin. Invest. 100, 3149–3153
38. Tran, T. T., Yamamoto, Y., Gesta, S., and Kahn, C. R. (2008) Beneficial
effects of subcutaneous fat transplantation on metabolism. Cell Metab. 7,
410–420
39. Flachs, P., Novotný, J., Baumruk, F., Bardová, K., Bourová, L., Miksík, I.,
Sponarová, J., Svoboda, P., andKopecký, J. (2002) Impaired noradrenaline-
induced lipolysis in white fat of aP2-Ucp1 transgenic mice is associated
with changes in G-protein levels. Biochem. J. 364, 369–376
40. Li, K., Li, L., Yang, M., Liu, H., Boden, G., and Yang, G. (2012) The effects
of fibroblast growth factor-21 knockdown and overexpression on its sig-
naling pathway and glucose-lipid metabolism in vitro.Mol. Cell. Endocri-
nol. 348, 21–26
41. Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic,
R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens,
R. A., Gromada, J., Brozinick, J. T., Hawkins, E. D., Wroblewski, V. J., Li,
D. S., Mehrbod, F., Jaskunas, S. R., and Shanafelt, A. B. (2005) FGF-21 as a
novel metabolic regulator. J. Clin. Invest. 115, 1627–1635
42. Coskun, T., Bina, H. A., Schneider, M. A., Dunbar, J. D., Hu, C. C., Chen,
Y.,Moller, D. E., andKharitonenkov, A. (2008) Fibroblast growth factor 21
corrects obesity in mice. Endocrinology 149, 6018–6027
43. Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonder-
fecht, S., Hecht, R., Li, Y. S., Lindberg, R. A., Chen, J. L., Jung, D. Y., Zhang,
Z., Ko, H. J., Kim, J. K., and Véniant,M.M. (2009) Fibroblast growth factor
21 reverses hepatic steatosis, increases energy expenditure, and improves
insulin sensitivity in diet-induced obese mice. Diabetes 58, 250–259
44. Gullberg, H., Rudling, M., Forrest, D., Angelin, B., and Vennström, B.
(2000) Thyroid hormone receptor -deficient mice show complete loss of
the normal cholesterol 7-hydroxylase (CYP7A) response to thyroid hor-
mone but display enhanced resistance to dietary cholesterol. Mol. Endo-
crinol. 14, 1739–1749
45. Gullberg, H., Rudling, M., Saltó, C., Forrest, D., Angelin, B., and
Vennström, B. (2002) Requirement for thyroid hormone receptor  in T3
regulation of cholesterol metabolism in mice. Mol. Endocrinol. 16,
1767–1777
46. Shin, D. J., Plateroti, M., Samarut, J., and Osborne, T. F. (2006) Two
uniquely arranged thyroid hormone-response elements in the far up-
stream 5
-flanking region confer direct thyroid hormone regulation to the
murine cholesterol 7-hydroxylase gene. Nucleic Acids Res. 34,
3853–3861
47. Adams, A. C., Astapova, I., Fisher, F. M., Badman,M. K., Kurgansky, K. E.,
Flier, J. S., Hollenberg, A. N., and Maratos-Flier, E. (2010) Thyroid hor-
mone regulates hepatic expression of fibroblast growth factor 21 in a
PPAR-dependent manner. J. Biol. Chem. 285, 14078–14082
48. Dasarathy, S., Yang, Y.,McCullough, A. J.,Marczewski, S., Bennett, C., and
Kalhan, S. C. (2011) Elevated hepatic fatty acid oxidation, high plasma
fibroblast growth factor 21, and fasting bile acids in nonalcoholic steato-
hepatitis. Eur. J. Gastroenterol. Hepatol. 23, 382–388
49. Rizki, G., Arnaboldi, L., Gabrielli, B., Yan, J., Lee, G. S., Ng, R. K., Turner,
S.M., Badger, T.M., Pitas, R. E., andMaher, J. J. (2006)Mice fed a lipogenic
methionine-choline-deficient diet develop hypermetabolism coincident
with hepatic suppression of SCD-1. J. Lipid Res. 47, 2280–2290
50. Raubenheimer, P. J., Nyirenda, M. J., and Walker, B. R. (2006) A choline-
deficient diet exacerbates fatty liver but attenuates insulin resistance and
glucose intolerance in mice fed a high fat diet. Diabetes 55, 2015–2020
51. Jacobs, R. L., Zhao, Y., Koonen,D. P., Sletten, T., Su, B., Lingrell, S., Cao,G.,
Peake, D. A., Kuo, M. S., Proctor, S. D., Kennedy, B. P., Dyck, J. R., and
Vance, D. E. (2010) Impaired de novo choline synthesis explains why phos-
phatidylethanolamine N-methyltransferase-deficient mice are protected
from diet-induced obesity. J. Biol. Chem. 285, 22403–22413
52. Wang, Y. Z., and Xu, Z. R. (1999) Effect of feeding betaine on weight gain
and carcass trait of barrows and gilts and approach to mechanism. J.
Zhejiang Agric. Univ. 25, 281–285
53. Xu, Z.,Wang,M., andHuai, M. (1999) The approach of themechanism of
growth-promoting effect of betaine on swine. Chin. J. Vet. Sci. 19, 399
54. Xu, Z., and Zhan, X. (1998) Effects of betaine on methionine and adipose
metabolism in broiler chicks. Acta Vet. Zoot. Sinica 29, 212–219
55. Yu, D., Feng, J., and Xu, Z. (2001) Effects of betaine on fat and protein
metabolism in different stages of swine. Chin. J. Vet. Sci. 21, 200–203
56. Yu, D. Y., and Xu, Z. R. (2000) Effects of methyl donor on the perfor-
mances and mechanisms of growth-promoting hormone in piglets. Chin.
J. Anim. Sci. 36, 8–10
57. Wang, Y. Z., Xu, Z. R., and ChenM. L. (2000) Effects of betaine on carcass
fat metabolism of meat duck. Chin. J. Vet. Sci. 20, 409–413
58. Zou, X. T. (2001) Effects of betaine on endocrinology of laying hens and its
mechanism of action. Chin. J. Vet. Sci. 21, 300–303
59. Zou, X. T., and Lu, J. J. (2002) Effects of betaine on the regulation of the
lipid metabolism in laying hen. Sci. China 1, 1043–1049
60. Zou, X. T., Ma, Y. L., and Xu, Z. R. (1998) Effects of betaine and thyropro-
tein on laying performance and approach to mechanism and effect in
hens. Acta Agriculturae Zhejiangensis 10, 144–149
61. Wang, Z., Yao, T., Pini, M., Zhou, Z., Fantuzzi, G., and Song, Z. (2010)
Betaine improved adipose tissue function in mice fed a high fat diet. A
mechanism for hepatoprotective effect of betaine in nonalcoholic fatty
liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 298, G634–G642
BHMT and Adiposity
16198 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 287 • NUMBER 20 • MAY 11, 2012
